We performed meta-regression to determine the association of treatment outcomes with patient characteristics and study design factors if significant heterogeneity was identified
Excitingly, clinical trials have proven that empagliflozin significantly reduces the relative risk of hospitalization for heart failure and cardiovascular death in T2DM patients with cardiovascular disease
The RER and energy expenditure (via the Weir equation) were calculated, while ambulatory activity was determined simultaneously
D.LownK
Currently, FDA-approved medications for chronic weight management include orlistat, phentermine/topiramate, naltrexone/bupropion, and liraglutide, but they can be expensive and have potential side effects
Both agents influence insulin secretion and metabolic hormones, but through different routes: one slows gastric emptying and reduces hunger through the GLP-1 pathway, while HCG is proposed to affect metabolic rate through separate endocrine mechanisms
